Randox Food Diagnostics Lead the Way with First Comprehensive Test for Coccidiostats

The wait is over for egg and poultry processors seeking a workable solution to screening for Coccidiostats with the welcome news of Randox Food Diagnostics bringing the first multi-analyte screening test to the market. As the Northern-Ireland headquartered firm grows its presence in the meat & poultry market the pioneering product is a direct result of customer demand, spending 24 months in development.

Coccidiosis is a parasitic disease of animal intestinal tracts caused by coccidian protozoa. Symptoms usually include bloody droppings, weight loss and mortality in young chickens. With no sign of the growth in global appetite for poultry meat waning (up by 50% since 2000), the pressure on producers to farm intensively is ever increasing. That in turn, leads to over-cramped conditions perfectly suited to the spread of coccidiosis amongst flocks.

To prevent infection, farmers may administer prophylactic antiprotozoal Coccidiostats in feed, which increases the chance that coccidiostat residues are retained in both poultry meat and eggs. To reduce the risk of toxicity to consumers, regulatory authorities have set Maximum Residue Limits (MRLs) recommending an appropriate withdrawal period prior to slaughter.

Mariclare McGarrity, Senior Customer Support Scientist explained why Randox Food Diagnostics were first to market with a comprehensive test.

“The key issue is the range of coccidiostat drugs utilized in the poultry industry. This leaves traditional single-analyte screening ELISA products unsuitable and inefficient. Producers are more likely to utilize confirmatory testing. However, Randox’s ground-breaking Biochip Array Technology is optimized for multiplex testing, identifying up to 22 different analytes from a single sample. As a result, it is an ideal platform to detect and quantify the whole range of commonly-used Coccidiostats throughout the global market.”

“Engaging with current and potential customers, we are keenly aware of the level of anticipation around this product, and we are confident it will meet the needs of a market seeking a cost-effective innovative solution.”